We have come a long way since the 1960s, when ethical questionsabout research involving human subjects brought the issue tonational attention. Nonetheless, the current system for safeguardingpeople who volunteer for clinical trials is under stress becauseof the unprecedented growth in clinical research.1,2,3 Since1995, federal funding for research has more than doubled. From1997 to 2000, the estimated number of participants in federallyfunded research increased from 7 million to almost 12 million4(and Seto B: personal communication). Privately sponsored clinicalresearch has grown at a similar pace.5 To paraphrase Snydermanand Holmes, as our ability . . . [Full Text of this Article]
Parvizi, J., Tarity, T. D., Conner, K., Smith, J. B.
(2007). Institutional Review Board Approval: Why It Matters. JBJS
89: 418-426
[Abstract][Full Text]
Lemaire, F.
(2006). Do all types of human research need ethics committee approval?. Am. J. Respir. Crit. Care Med.
174: 363-364
[Full Text]
McWilliams, R., Hoover-Fong, J., Hamosh, A., Beck, S., Beaty, T., Cutting, G.
(2003). Problematic Variation in Local Institutional Review of a Multicenter Genetic Epidemiology Study. JAMA
290: 360-366
[Abstract][Full Text]
Emanuel, E. J., Kornfeld, D. S., Mann, H., Paasche-Orlow, M. K., Taggart, J. C.
(2002). Institutional Review Board Reform. NEJM
347: 1285-1286
[Full Text]
Barnes, M., Florencio, P. S.
(2002). Financial Conflicts of Interest in Human Subjects Research: The Problem of Institutional Conflicts. J Law Med Ethics
30: 390-402
Martinez, S. A.
(2002). Currents in Contemporary Ethics. J Law Med Ethics
30: 452-454